Box of palbociclib breast cancer drug capsules. This drug, marketed as Ibrance, is a kinase inhibitor. It acts on cyclin-dependent kinases 4 and 6, which regulate the cell cycle. Blocking their action prevents cell division and the growth of the cancer. | |
Licence : | Droits gérés |
Crédit: | Science Photo Library / Marazzi, Dr. P. |
Taille de l’image : | 6048 px × 4024 px |
Model Release : | Disponible |
Property Release : | Non requis |
Restrictions : |
|